The PE Ratio as of November 2024 (TTM) for Scholar Rock Holding Corporation (SRRK) is -12.68

According to Scholar Rock Holding Corporation’s latest financial reports and current stock price. The company's current PE Ratio is -12.68. This represents a change of 139.26% compared to the average of -5.30 of the last 4 quarters.

Scholar Rock Holding Corporation (SRRK) Historical PE Ratio (quarterly & annually)

How has SRRK PE Ratio performed in the past?

The mean historical PE Ratio of Scholar Rock Holding Corporation over the last ten years is -10.10. The current -12.68 PE Ratio has changed 12.45% with respect to the historical average. Over the past ten years (40 quarters), SRRK's PE Ratio was at its highest in in the June 2022 quarter at -1.27. The PE Ratio was at its lowest in in the March 2021 quarter at -16.65.

Scholar Rock Holding Corporation (SRRK) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Scholar Rock Holding Corporation PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Scholar Rock Holding Corporation (SRRK) Average PE Ratio

How has SRRK PE Ratio performed in the past?

The current PE Ratio of Scholar Rock Holding Corporation (SRRK) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Scholar Rock Holding Corporation (SRRK) PE Ratio vs. Peers

How is SRRK’s PE Ratio compared to its peers?

Scholar Rock Holding Corporation’s PE Ratio is less than TCR2 Therapeutics Inc. (-0.38), greater than Revolution Medicines, Inc. (-16.70), less than Black Diamond Therapeutics, Inc. (-1.96), less than Atreca, Inc. (-0.06), less than Passage Bio, Inc. (-0.45), less than Monte Rosa Therapeutics, Inc. (-5.83), less than Design Therapeutics, Inc. (-6.66), less than Werewolf Therapeutics, Inc. (-1.34), less than Ikena Oncology, Inc. (-1.38), less than Stoke Therapeutics, Inc. (-6.11), greater than IDEAYA Biosciences, Inc. (-12.96), less than AnaptysBio, Inc. (-3.88), less than MeiraGTx Holdings plc (-4.82), less than Keros Therapeutics, Inc. (-11.12), less than Homology Medicines, Inc. (-0.01), greater than Avidity Biosciences, Inc. (-19.02), less than IGM Biosciences, Inc. (-2.45), greater than Cerevel Therapeutics Holdings, Inc. (-17.73), less than Cullinan Oncology, Inc. (-5.10), less than Mineralys Therapeutics, Inc. (-4.06), less than Relay Therapeutics, Inc. (-1.93), less than Pliant Therapeutics, Inc. (-3.91), less than Arvinas, Inc. (-6.04),

Build a custom stock screener for Scholar Rock Holding Corporation (SRRK) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Scholar Rock Holding Corporation using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Scholar Rock Holding Corporation (SRRK) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Scholar Rock Holding Corporation or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.